Align Technology | ALGN - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
3M USD 2.46B 398M 2026-03
Align Technology USD 736.59M 53M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bruker USD 379.8M 69.4M 2026-03
Cardinal Health USD 2.5B 101M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
CVS Health USD 15.62B 2.06B 2026-03
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 427M 16M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Henry Schein USD 1.07B 7M 2026-03
Idexx Laboratories USD 722.74M 64.62M 2026-03
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Masimo USD 250.8M 3.5M 2026-03
McKesson USD 3.68B 143M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Revvity USD 387.66M 34M 2026-03
Solventum Corp USD 1.1B 70M 2026-03
Stryker USD 3.81B 675M 2026-03
Teleflex USD 307.43M 21K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veeva Systems USD 678.61M 56.14M 2026-03
Waters USD 542M 15.42M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12
Zoetis USD 1.62B 20M 2026-03